|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluating the role of inflam- mation in chronic airways disease: the ERICA study显示文摘 | Mohan D Gale NS McEniery CM | 2014 | COPD2014，11，5： | 1 |
| 2 | Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation显示文摘 | Gale M Jr Blakely CM Kwieciszewski B | 1998 | Mol Cell Biol1998，18，： | 1 |
| 3 | Molar apicectomy with amalgam root-end filling:Results of a prospective study in two district general hospitals显示文摘 | Wesson CM Gale TM | | 0，，12： | 1 |
| 4 | PF00299804,an irreversible pan-ERBB inhibitor,is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib显示文摘 | Engelman JA Zejnullahu K Gale CM | 2007 | Cancer Res2007，67，11： | 1 |
| 5 | Jr Human masticatory muscle activity and jaw position under experimental stress 显示文摘 | Tsai CM Chou SL Gale EN | 2002 | J Oral Rebabil2002，29，1： | 1 |
| 6 | Human masticatory muscle activity and jaw position under experimental stress显示文摘 | Tsai CM Chou SL Gale EN | 2002 | J Oral Rehabil2002，29，1： | 1 |
| 7 | Antibiotic use and upper respiratory infections:a survey of knowledge, attitudes,and experience in Wisconsinand Minnesota显示文摘 | Belongia EA Naimi TS Gale CM | 2002 | Pre Mede2002，34，3： | 1 |
| 8 | Human masticatory muscle activity and jaw position under experimental stress显示文摘 | Tsai CM Chou SL Gale EN | 2002 | J Oral Rehabil2002，29，1： | 1 |
| 9 | PF00299804,an irreversible pan-ERBB inhibitor,is effective in lung Cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib显示文摘 | Engelman JA Zejnullahu K Gale CM | | 0，，24： | 1 |
| 10 | PF00299804, an irreversible pan -ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib 显示文摘 | Engelman JA Zejnullahu K Gale CM | 2007 | Cancer Res2007，67，11： | 1 |
| 11 | Control of PKRprotein kinase by hepatitis C virus nonstructural 5A protein:molecular mechanisms of kinase regulation显示文摘 | Gale M Jr Blakely CM Kwieciszewski B | 1998 | Mol Cell Biol1998，18，9： | 1 |
| 12 | PFOO299ll(?, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib显示文摘 | Engelman lA Zejnullahu K Gale CM | 2007 | Cancer Res2007，67，11： | 1 |
| 13 | PF00299804,an irrevers- ible pan-ERBB inhibitor,is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib显示文摘 | Engelman JA Zejnullahu K Gale CM | 2007 | Can- cer Res2007，67，11： | 1 |
| 14 | PF00299804,an irreversible pan–ERBB inhibitor,is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib显示文摘 | Engelman JA Zejnullahu K Gale CM | | 0，，： | 1 |
| 15 | Molar apicectomy with amalgam root-end filling:Results of a prospective study in two district general hospitals显示文摘 | Wesson CM Gale TM | 2003 | Br Dent J2003，195，12： | 1 |
| 16 | Linkage of adhesion,filamentous growth, and virulence in Candida albicans to a single gene, INT1 显示文摘 | Gale CA Bendel CM McClellan M | 1998 | Science1998，279，： | 1 |
| 17 | Evaluating the role of in-flammation in chronic airways disease: the ERICA study显示文摘 | Mohan D Gale NS McEniery CM | 2014 | COPD2014，11，5： | 1 |
| 18 | PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer mod- els with EGFR and ERBB2 mutations that are resistant to gefitinib 显示文摘 | Engelman JA Zejnullahu K Gale CM | 2007 | Cancer Res2007，67，11： | 1 |
| 19 | Molar apicoentomy with amalgam root - end filling : results of a prospective study in two district gengral hospitals 显示文摘 | Wesson CM Gale TM | 2003 | Br Dent J2003，195，： | 1 |
| 20 | Regulation of interferon-induced protein kinase PKR:modulation of P58(IPK) inhibitory function by a novel protein P52(rIPK)显示文摘 | Gale M Jr Blakely CM Hopkins DA | 1998 | Mol Cell Biol1998，18，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员